Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours (Q42645259)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours |
scientific article |
Statements
1 reference
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours (English)
1 reference
1 reference
Hester van Cruijsen
1 reference
Emile E Voest
1 reference
Cornelis J A Punt
1 reference
Klaas Hoekman
1 reference
Petronella O Witteveen
1 reference
Martijn R Meijerink
1 reference
Thomas A Puchalski
1 reference
Jane Robertson
1 reference
Owain Saunders
1 reference
Juliane M Jürgensmeier
1 reference
Carla M L van Herpen
1 reference
12 January 2010
1 reference
1 reference
Identifiers
1 reference